Citation Impact
Citing Papers
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
2012 Standout
Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells
2012
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma
2016
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer
2013
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours
2013
Transition from inflammation to proliferation: a critical step during wound healing
2016 Standout
Head and neck squamous cell carcinoma
2020 Standout
The Biogenesis, Functions, and Challenges of Circular RNAs
2018 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
2015
Atopic dermatitis
2003 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
2009 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures
2005
Extremely durable biofouling-resistant metallic surfaces based on electrodeposited nanoporous tungstite films on steel
2015
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Atopic dermatitis
2015 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment
2017
Vessel co-option in cancer
2019
Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies
2013
Lung Cancer
2008 Standout
Atopic Dermatitis: Global Epidemiology and Risk Factors
2015 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Effects of Immunosuppressants on Receptor Activator of NF-κB Ligand and Osteoprotegerin Production by Human Osteoblastic and Coronary Artery Smooth Muscle Cells
2001
Advances in using PARP inhibitors to treat cancer
2012
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors
2009
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
2014
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
2015
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
2010 Standout
3D bioactive composite scaffolds for bone tissue engineering
2017 Standout
The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats
2004
Synthesis and biological evaluation of a triazole-based library of pyrido[2,3-d]pyrimidines as FGFR3 tyrosine kinase inhibitors
2010
Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer
2015
Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models
2015
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention
2014 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
The use of combinations of monoclonal antibodies in clinical oncology
2015
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing
2015
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout
The roles of TGFβ in the tumour microenvironment
2013
The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: The Bristol-Myers Squibb experience
2014
The complexity of prostate cancer: genomic alterations and heterogeneity
2012
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
2011
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
2014
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
Anaplastic lymphoma kinase as a therapeutic target
2012
Surface treatments of titanium dental implants for rapid osseointegration
2006 Standout
Crizotinib in the Treatment of Non–Small-Cell Lung Cancer
2013
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
2013
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Bioactive lipid mediators in skin inflammation and immunity
2012
Molecular pathogenesis of mantle cell lymphoma
2012
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Nomogram Predictive of Cancer Specific Survival in Patients Undergoing Partial or Total Amputation for Squamous Cell Carcinoma of the Penis
2006
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Systematic review of treatments for atopic eczema.
2000
High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients
2014
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer
2014
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
2014 Standout
Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
2013
Dietary supplements for established atopic eczema
2012
Myeloproliferative neoplasms: Morphology and clinical practice
2015
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma
2016 StandoutNobel
Combination therapy in combating cancer
2017 Standout
Inhibitors of the anaplastic lymphoma kinase
2012
Design of anti-icing surfaces: smooth, textured or slippery?
2016 Standout
Cancer Genome Landscapes
2013 StandoutScience
Natural product and natural product derived drugs in clinical trials
2014 Standout
Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer
2014
Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing
2017
Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic Options
2013
Alendronate-loaded hydroxyapatite-TiO2nanotubes for improved bone formation in osteoporotic rabbits
2016
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Vascular Calcification
2004 Standout
Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients
2005
Works of Sérgio Serrano being referenced
AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer
2013
FGFR3 mutations in prostate cancer: association with low-grade tumors
2009
Effect of alendronate on cultured normal human osteoblasts
1998
Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas
2010
MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines
2011
A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer
2012
Expression profiles associated with aggressive behavior in Merkel cell carcinoma
2006
Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype
2015
Iliac nodal metastases from carcinoma of the penis treated surgically
2000
Effect of cyclosporine A on normal human osteoblasts in vitro
1994
Gastrointestinal Involvement in Mantle Cell Lymphoma: A Prospective Clinic, Endoscopic, and Pathologic Study
2006
Effects of Linoleic Acid Supplements on Atopic Dermatitis
1997
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
2011
Persistent monoclonality after histological remission in gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy and/or surgery: Influence of t(11;18)(q21;q21)
2008
Characterization of HER1 (c-erbB1) Status in Locally Advanced Breast Cancer Using Fluorescence in situ Hybridization and Immunohistochemistry
2005
Surgical site infection: An observer-blind, randomized trial comparing electrocautery and conventional scalpel
2014
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
2011
PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events
2010
Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer
2010
Ipilimumab for stage unresectable III/IV melanoma: Brazilian experience in an expanded access program.
2014
Overall survival (OS) and safety of dasatinib/docetaxel versus docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC): Results from the randomized phase III READY trial.
2013
Absence of TGF-βRII predicts bone and lung metastasis and is associated with poor prognosis in stage III breast tumors
2012
2014